So many amazing things happen to us as we get older: we're wiser, more confident and more comfortable in our own skin. But ...

Spironolactone showed no significant benefit in reducing the composite of cardiovascular mortality and heart failure ...

Can an influencer who’s taken Accutane sell acne products? We asked six dermatologists to weigh in on Alix Earle’s skin-care ...

A trial testing the aldosterone blocker spironolactone in patients with heart failure with preserved ejection fraction (HFpEF) and heart failure with mildly reduced ejection fraction (HFmrEF) did not ...

The trial enrolled just half of its planned patients, leaving spironolactone’s role in HFpEF and HFmrEF still up in the air.

Baxdrostat, a new blood pressure drug, cut systolic BP by 9-10 mmHg in trials and may benefit Indian patients with resistant ...

No reduction seen in the composite outcome of cardiovascular mortality, hospitalization due to heart failure. HealthDay News — Spironolactone does not reduce a composite outcome of cardiovascular ...

A large international study has found that spironolactone, a medication for high blood pressure and heart failure, does not reduce the risk of heart-related death or hospitalizations in people with ...

‘New research on #spironolactone in #dialysis patients found no #cardiovascular benefits. It also raised the risk of severe #hyperkalemia, a dangerous increase in #blood_potassium. What does this mean ...

Daily treatment with a mineralocorticoid receptor antagonist flopped for reducing serious cardiac events in kidney failure patients on maintenance dialysis, a randomized trial found. Among over 2,500 ...